Innovating Works

H2020

Cerrada
HORIZON-JU-IHI-2022-01-01
An innovative decision-support system for improved care pathways for patients with neurodegenerative diseases and comorbidities
ExpectedOutcome:R&I actions to be supported under this topic shall contribute to the following outcomes:
Sólo fondo perdido 7.0M €
Europeo
Mostrando 41 al 45 de 45 resultados
SUSTAINEXT: NEXT GENERATION ZERO WASTE DYNAMIC MULTIVALORIZATION ROUTE BIOREFINERY FOR SUSTAINABLE BOTANICAL... NATAC BIOTECH tramitó un HORIZON EUROPE: HORIZON-JU-CBE-2022-IAFlag-01 SUSTAINEXT is led by Natac and brings together 21 partners from Europe and Spain, 7 of them from the Extremadura region. The project will st...
2023-05-05 - 2027-11-30 | Financiado
IMAGIO: IMAGING AND ADVANCED GUIDANCE FOR WORKFLOW OPTIMIZATION IN INTERVENTIONAL ONCOLOGY PHILIPS MEDICAL SYSTEMS NEDERLAND BV tramitó un HORIZON EUROPE: HORIZON-JU-IHI-2022-01-04 Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. Lung and liver c...
2023-05-01 - 2027-04-30 | Financiado
Bio-LUSH: BIOMASS VALORIZATION FOR SUSTAINABLE AND HIGH QUALITY FIBER MATERIALS STOCKHOLMS UNIVERSITET tramitó un HORIZON EUROPE: HORIZON-JU-CBE-2022-R-05 Bio-LUSH addresses a growing need and demand to utilize underexploited biomass feedstocks for sustainable and high-quality fibre extraction....
2023-05-01 - 2027-04-30 | Financiado
PROMINENT: PRECISION MEDICINE PLATFORM IN NEURODEGENERATIVE DISEASE KAROLINSKA INSTITUTET tramitó un HORIZON EUROPE: HORIZON-JU-IHI-2022-01-01 Neurodegenerative diseases are one of the most important contributors to morbidity and mortality in the elderly. In Europe, over 14 million...
2023-04-25 - 2028-04-30 | Financiado
IDERHA: Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG EV tramitó un HORIZON EUROPE: HORIZON-JU-IHI-2022-01-04 IDERHA will address the key obstacles to achieving appropriate access, sharing, use and reuse of lung cancer data, and thus enable enhanced...
2023-04-01 - 2028-03-31 | Financiado